Cognition Therapeutics's total assets for Q2 2025 were $19.62M, a decrease of -16.50% from the previous quarter. CGTX total liabilities were $12.59M for the fiscal quarter, a 12.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.